Skip to content

The effect of pretreatment with vaginal microbial supplement on the outcomes of freeze-embryo transfer cycles in infertile women

The effect of pretreatment with vaginal microbial supplement on the outcomes of freeze-embryo transfer cycles in infertile women

Status
Recruiting
Phases
Phase 4
Study type
Interventional
Source
IRCT
Registry ID
IRCT20091012002576N17
Enrollment
90
Registered
2019-04-06
Start date
2019-01-21
Completion date
Unknown
Last updated
2019-04-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Recurrent IVF failure. Recurrent IVF failure

Interventions

Intervention group: forty five patients include in the case group and received lactatovage suppository two weeks before embryo transfer..

Sponsors

Tehran University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
20 Years to 40 Years

Inclusion criteria

Inclusion criteria: Having freeze embryos from the previous IVF cycle Age 20 to 40 years old lack of anatomical lesions in the uterus absence of vaginitis and cervicitis

Exclusion criteria

Exclusion criteria: Patients with known genetic disease on their own or spouse People with certain systemic or chronic diseases (diabetes, hypertension, endocrine problems, autoimmune diseases, endometriosis, etc.) Embryos that frozen more than 5 years. Embryos with poor quality after thowing Vaginal infection or cervicitis

Design outcomes

Primary

MeasureTime frame
Embryo implantation. Timepoint: 2 weeks. Method of measurement: B HCG titrage.

Secondary

MeasureTime frame
Checking gestational sac in ultrasound. Timepoint: 4 weeks. Method of measurement: ultrasound.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactFatemeh Davari Tanha

Tehran University of Medical Sciences

fatedavtanha@gmail.com+98 21 8880 0611

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026